• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Policy and Guidelines

Updated FDA Guidance to Reduce Risk of Transmission of Creutzfeldt-Jakob Disease

The U.S. Food and Drug Administration (FDA) has issued updated guidance to reduce the transfusion-related transmission risk of Creutzfeldt-Jakob disease…

June 1, 2022

Updated Transfusion Guidelines for High-Risk Surgery Patients

Patient blood management programs use a multimodal approach to conserve blood and simultaneously improve patient outcomes.  Transfusion guidelines are central…

February 16, 2022

Minimal Concerns for HIV in the US Blood Supply after FDA Revised Guidance

In 2015, the U.S. FDA revised guidance for blood donor deferral of men who have sex with men (MSM) from…

September 15, 2020

FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma

To increase access to COVID-19 convalescent plasma (CCP) use, President Trump, in conjunction with the U.S. FDA, announced Emergency Use…

August 25, 2020

Coagulopathy in Patients with COVID-19—Interim Guidance from the International Society on Thrombosis and Haemostasis

Although the pathophysiology of severe COVID-19 is poorly understood, coagulopathy near the lungs has been shown to play an important…

May 13, 2020

FDA Alters Blood Donor Eligibility Guidelines during COVID-19 Public Health Emergency

The U.S. Food and Drug Administration (FDA) issued four blood donor eligibility guidelines on April 2, 2020 to help alleviate…

April 7, 2020

Final FDA Guidance to Reduce Transfusion-Transmitted Human T-Lymphotropic Virus Types I and II

Transmission of the retroviruses human T-lymphotropic virus types I and II (HTLV-I/II) require cell-to-cell contact—mother to child transmission, sexual transmission,…

February 12, 2020

New Draft Guidance Recommendations from the FDA to Reduce Risk of Transfusion-Transmitted Creutzfeldt-Jakob Diseases

Creutzfeldt-Jakob Disease (CJD) is a fatal, rare neurological disease caused by infectious prions, or abnormally folded proteins.  Sporadic CJD accounts…

February 5, 2020

FDA Guidance to Control for Bacterial Contamination in Platelets

The U.S. Food and Drug Administration (FDA) has issued final guidance to reduce bacterial contamination of platelets stored at room…

October 9, 2019

New FDA Recommendations for Babesiosis Screening of Blood Donations

Babesiosis, caused by a tick-borne intra-erythrocytic parasite, is normally asymptomatic in humans but can cause severe and even deadly flu-like…

May 16, 2019

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 6
  • Go to Next Page »

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley